Ranger Investment Management’s West Pharmaceutical WST Stock Holding History

Ranger Investment Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-24	Closed	-$7.86K	–	94
2024 Q4	$7.86K	Sell	24 -10	-29%	-$3.15K	﹤0.01%	79
2024 Q3	$10.2K	Hold	34	–	–	﹤0.01%	78
2024 Q2	$11.2K	Hold	34	–	–	﹤0.01%	80
2024 Q1	$13.5K	Sell	34 -4	-11%	-$1.48K	﹤0.01%	76
2023 Q4	$13.4K	Buy	38 +21	+124%	+$7.43K	﹤0.01%	78
2023 Q3	$6.38K	Hold	17	–	–	﹤0.01%	88
2023 Q2	$6.5K	Hold	17	–	–	﹤0.01%	88
2023 Q1	$5.89K	Hold	17	–	–	﹤0.01%	89
2022 Q4	$4K	Hold	17	–	–	﹤0.01%	92
2022 Q3	$4K	Hold	17	–	–	﹤0.01%	97
2022 Q2	$5K	Sell	17 -5	-23%	-$1.63K	﹤0.01%	91
2022 Q1	$9K	Hold	22	–	–	﹤0.01%	84
2021 Q4	$10K	Hold	22	–	–	﹤0.01%	82
2021 Q3	$9K	Hold	22	–	–	﹤0.01%	93
2021 Q2	$8K	Buy	22 +7	+47%	+$2.31K	﹤0.01%	94
2021 Q1	$4K	Hold	15	–	–	﹤0.01%	101
2020 Q4	$4K	Sell	15 -6	-29%	-$1.68K	﹤0.01%	97
2020 Q3	$6K	Hold	21	–	–	﹤0.01%	98
2020 Q2	$5K	Sell	21 -9	-30%	-$1.77K	﹤0.01%	95
2020 Q1	$5K	Hold	30	–	–	﹤0.01%	97
2019 Q4	$5K	Hold	30	–	–	﹤0.01%	108
2019 Q3	$4K	Hold	30	–	–	﹤0.01%	104
2019 Q2	$4K	Hold	30	–	–	﹤0.01%	112
2019 Q1	$3K	Hold	30	–	–	﹤0.01%	114
2018 Q4	$3K	Hold	30	–	–	﹤0.01%	114
2018 Q3	$4K	Hold	30	–	–	﹤0.01%	107
2018 Q2	$3K	Hold	30	–	–	﹤0.01%	132
2018 Q1	$3K	Hold	30	–	–	﹤0.01%	132
2017 Q4	$3K	Buy	30 +3	+11%	+$294	﹤0.01%	136
2017 Q3	$3K	Sell	27 -9	-25%	-$814	﹤0.01%	135
2017 Q2	$3K	Hold	36	–	–	﹤0.01%	142
2017 Q1	$3K	Buy	+36	New	+$3.01K	﹤0.01%	146

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return

Ranger Investment Management's WST Position: Q1 2025 in Review

Ranger Investment Management sold out of West Pharmaceutical (WST) in Q1 2025, closing a stake of 24 shares — an estimated $7.86K sold.

Ranger Investment Management first reported a position in WST in Q1 2017 and held it in 32 quarters. The position peaked at $13.5K in Q1 2024. 715 funds tracked by Wall St. Rank hold WST as of Q1 2025.

Ranger Investment Management reported no remaining West Pharmaceutical position as of Q1 2025 after selling out during the quarter.
Ranger Investment Management sold 24 West Pharmaceutical shares in Q1 2025, an estimated $7.86K.
Ranger Investment Management first reported a position in West Pharmaceutical in Q1 2017 and held it in 32 quarters.
Ranger Investment Management's West Pharmaceutical position peaked at $13.5K in Q1 2024.
715 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2025.

Based on Ranger Investment Management's 13F filing for Q1 2025, filed 15 May 2025.